EQIS CAPITAL MANAGEMENT, INC. – CRISPR Therapeutics AG Transaction History
EQIS CAPITAL MANAGEMENT, INC. portfolio value:
$1.72M
portfolio value
EQIS CAPITAL MANAGEMENT, INC. quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +106.56% | 13.63K shares | 949.82K | $65.35 | 26.43K |
| Q2 2022 | share | Decrease | -29.12% | -5.25K shares | -355.17K | $60.77 | 12.79K |
| Q1 2022 | share | Decrease | -25.47% | -6.17K shares | -703K | $62.77 | 18.05K |
| Q4 2021 | share | Increase | +1.20% | 287 shares | -844K | $78.85 | 24.22K |
| Q3 2021 | share | Increase | +12.16% | 2.59K shares | -776K | $111.93 | 23.94K |
| Q2 2021 | share | Decrease | -7.23% | -1.66K shares | 652K | $161.89 | 21.34K |
| Q1 2021 | share | Increase | 0.00% | 23.00K shares | 2.80M | $121.85 | 23.00K |